- Diagnostic Différentiel
Drug Information for HydrOXYzine hydrochloride (Caraco Pharmaceutical Laboratories, Ltd.): CONTRAINDICATIONS
- CLINICAL PHARMACOLOGY
- INDICATIONS AND USAGE
- ADVERSE REACTIONS
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- PACKAGE LABEL.PRINCIPAL DISPLAY PANEL- 10 mg 100 count
- PACKAGE LABEL.PRINCIPAL DISPLAY PANEL- 25 mg 100 count
- PACKAGE LABEL.PRINCIPAL DISPLAY PANEL- 50 mg 100 count
- Liens externes liés à HydrOXYzine hydrochloride (Caraco Pharmaceutical Laboratories, Ltd.)
HydrOXYzine, when administered to the pregnant mouse, rat, and rabbit induced fetal abnormalities in the rat and mouse at doses substantially above the human therapeutic range. Clinical data in human beings are inadequate to establish safety in early pregnancy. Until such data are available, hydrOXYzine is contraindicated in early pregnancy.
HydrOXYzine is contraindicated for patients who have shown a previous hypersensitivity to it.
- Drug Information Provided by National Library of Medicine (NLM).